Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients.
about
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosisSystemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report.Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetilInfliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.Targeting the TNF-alpha pathway in sarcoidosis.Infliximab therapy for hepatic and intestinal sarcoidosis.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesUpdate on the use of systemic biologic agents in the treatment of noninfectious uveitis.Review series: Aspects of interstitial lung disease. Sarcoidosis.Tumor necrosis factor biologics beyond psoriasis in dermatology.Long-term treatment with infliximab in patients with sarcoidosis.Anti-TNF therapeutics for the treatment of sarcoidosis.Pituitary stalk lesions: systematic review and clinical guidance.Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis.Sarcoidosis: an update on current pharmacotherapy options and future directions.Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.Pins and needles and unilateral foot drop: a presentation of sarcoidosis.Ocular Sarcoidosis.
P2860
Q24652971-29CC7665-FF8E-4DAE-BF6C-94388FE51C42Q33386650-A7182BCC-9764-4C68-8F81-268F0487134AQ33403151-2D4C81C5-3131-450C-B6B7-D2F677D95E6BQ33997625-E064FEA2-3771-4D30-9B0A-0D4F349FBC6AQ34087381-AC1714D1-EEB6-4029-8A81-49AA720D6E94Q34996785-EFEE831F-AFF9-4117-84EA-50D9F5B9E01BQ36724093-5E0C1C97-0185-4371-9BEB-B277DAF8B23AQ37600483-CBCF089A-22A1-4D5E-8946-1EC35A624E95Q37810386-2B6015DA-CFD2-4C4D-BB6C-180D65868F92Q37886194-BE9EA550-CA07-41CE-AA35-FEEEEA9740EDQ37910659-0C5A920C-A56F-472E-9A5A-3C121E2F6FBDQ38271881-43E8A388-2337-4122-99D8-B77FEEF00FC2Q38763808-924FC7F2-5EE5-48EA-96D5-BBEC264DA23BQ38773144-19574060-615D-4F43-8FAD-5FCF00C63B37Q38798146-2397D719-645B-499F-B5D4-C447C796A490Q40837020-80241D9C-8E94-45FD-8423-E1C3DFFC53E3Q42025279-7194A989-EA94-47E6-B6E5-B363B732D27EQ54886359-B5E8891E-77B8-47E2-AAD2-0A3A693BE2BB
P2860
Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@ast
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@en
type
label
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@ast
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@en
prefLabel
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@ast
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@en
P356
P1476
Tumour necrosis factor alpha i ...... ts: a report of five patients.
@en
P2093
Nadarajah K
Pritchard C
P304
P356
10.1136/ARD.2002.004226
P407
P577
2004-03-01T00:00:00Z